Skip to main content
. 2020 Jun 23;9(6):1959. doi: 10.3390/jcm9061959

Table 3.

Predictive models for disease severity and progression of patients with COVID-19 *.

Total, No. (%) Progression, No. (%) Improvement/Stabilization, No. (%) p
(n = 293) (n = 36) (n = 257) Value AUC 95% CI Sensitivity Specificity
KCDC classification I <0.001 0.817 (0.740–0.895) 83.30% 67.70%
 Class I 180 (61.4%) 6 (16.7%) 174 (67.7%)
 Class II 91 (31.1%) 14 (38.9%) 77 (30.0%)
 Class III 22 (7.5%) 16 (44.4%) 6 (2.3%)
KCDC classification II <0.001 0.676 (0.590–0.762) 52.80% 82.50%
 Class I 229 (78.2%) 17 (47.2%) 212 (82.5%)
 Class III 64 (21.8%) 19 (52.8%) 45 (17.5%)
CT score, median (IQR) 0.0 (0.0–4.0) 6.2 (1.0–14.5) 0.0 (0.0–3.0) <0.001 0.768 (0.680–0.856) 77.80% 65.00%
MuLBSTA, median (IQR) 0.0 (0.0–5.0) 5.0 (5.0–7.0) 0.0 (0.0–5.0) <0.001 0.744 (0.662–0.825) 77.80% 63.80%
CURB65 <0.001 0.575 (0.507–0.642) 19.40% 95.30%
 0 274 (93.5%) 29 (80.6%) 245 (95.3%)
 1 18 (6.1%) 6 (16.7%) 12 (4.7%)
 2 1 (0.3%) 1 (2.8%) 0 (0.0%)
Pneumonia severity index <0.001 0.659 (0.568–0.750) 50.00% 79.00%
 Class I 221 (75.4%) 18 (50.0%) 203 (79.0%)
 Class II 53 (18.1%) 10 (27.8%) 43 (16.7%)
 Class III 17 (5.8%) 6 (16.7%) 11 (4.3%)
 Class IV 2 (0.7%) 2 (5.6%) 0 (0.0%)
Age-adjusted Charlson comorbidity index, median (IQR) 0.0 (0.0–1.0) 1.0 (0.5–4.0) 0.0 (0.0–1.0) <0.001 0.703 (0.610–0.795) 75.00% 56.80%

* AUC, area under the curve; CI, confidence interval; KCDC, Korea Centers for Disease Control and Prevention; CT, computed tomography, IQR, interquartile range; MuLBSTA, Multilobular infiltration, hypo-Lymphocytosis, Bacterial coinfection, Smoking history, hyper-Tension and Age; CURB65, Confusion, Urea, Respiratory rate, Blood pressure plus age ≥ 65 years.